about
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia.Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes.C9ORF72 repeat expansion not detected in patients with multiple sclerosis.Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy.Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis.Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis.Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses.Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients.CSF β-amyloid and white matter damage: a new perspective on Alzheimer's disease.Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations.Brain temperature in multiple sclerosis.Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod.Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation.The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia.Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutationPhenotypic Heterogeneity of the GRN Asp22fs Mutation in a Large Italian KindredBehavioral and Neurophysiological Effects of Transcranial Direct Current Stimulation (tDCS) in Fronto-Temporal DementiaSciatic endometriosis presenting as periodic (catamenial) sciatic radiculopathyStructural and metabolic cerebral alterations between elderly bipolar disorder and behavioural variant frontotemporal dementia: A combined MRI-PET studyTesting the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromesCSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosisMonozygotic Twins with Frontotemporal Dementia Due To Thr272fs GRN Mutation Discordant for Age At OnsetInflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola DiseaseLow CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosisCerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression
P50
Q30402493-845BC614-5B98-4FDF-A235-B68A92441DDCQ33946311-47605B3A-AF7D-4057-847C-678765267040Q35072060-40747EB3-AE97-468E-8153-BD10DC7CE0CAQ35812786-2C3C33D9-A16B-4343-97BA-E5A024036E1CQ36159942-E76FC030-873D-46C5-A0C8-1E92A304B978Q36790311-1EEDCC49-2191-45F6-91A7-B76E0E7B0EE8Q40317591-ACC9BFB5-6EE0-4ADF-B32E-D1AD983D217BQ42248880-949652DB-86B5-4070-BE90-C7A94DD565CAQ47975609-89ECB0C5-97C8-496B-80C3-81FA28022EF8Q47975873-2E211E33-84D4-49E3-A1E7-876B53C2FB9FQ48008798-A27D3049-F3E6-4E97-AD3B-6386947EFEDCQ48110734-359C3DC2-5B4B-4187-B21E-BE600BE0B997Q48474028-C4ED3355-8C21-402D-B029-5DFA0A3CD27BQ48522755-54ABAF8A-31BA-4DAD-BD5A-52771B41022DQ48911939-5E84FD1E-674B-4A3A-B371-F24875A7E9B7Q49388044-CF22893F-BD94-44CF-A88D-2D61C26F41C4Q49988030-670ED5E0-57E4-434A-81DE-D9060941F02EQ50620554-ED4557DE-45A9-492C-B150-20BCB56D547BQ53306741-771F36D9-8C8E-43D4-A31A-9DC5256E9430Q57898470-7B3D183C-9D46-4B8B-99C7-78AF970F0861Q57898498-0335460C-B736-4D04-A4FE-748EBDA9992FQ58694876-865F6F6F-3834-4321-AA61-D9BDF97981E7Q59543678-5D00678C-F4BF-41DE-9C4D-177F0E448E0BQ90458433-A1869D72-97D5-45E1-8836-26E8E387496FQ90727860-639A811C-2061-4740-890B-408C165E3C87Q91036002-17BF459A-B502-4E79-9C1B-EA70990FB726Q91250214-A576B36F-3F06-432E-A817-0074C1DDF911Q91251778-6192E97B-B693-4649-B52D-6D0B71E0074AQ92300171-761AAA87-21E7-4369-96E8-A6AE95238FDEQ92476685-6312E6C2-AC5B-4064-8633-337CEF2D346EQ95940207-EB803ACB-8273-4AD9-88D8-FF0DAE53DF2E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna M. Pietroboni
@ast
Anna M. Pietroboni
@en
Anna M. Pietroboni
@es
Anna M. Pietroboni
@nl
Anna M. Pietroboni
@sl
type
label
Anna M. Pietroboni
@ast
Anna M. Pietroboni
@en
Anna M. Pietroboni
@es
Anna M. Pietroboni
@nl
Anna M. Pietroboni
@sl
prefLabel
Anna M. Pietroboni
@ast
Anna M. Pietroboni
@en
Anna M. Pietroboni
@es
Anna M. Pietroboni
@nl
Anna M. Pietroboni
@sl
P1053
L-2970-2015
P106
P1153
35867511200
P21
P31
P3829
P496
0000-0003-1538-1830